EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 26 filers reported holding EVOGENE LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,679 | – | 35,258 | +49559.2% | 0.00% | – |
Q1 2023 | $0 | – | 71 | -48.2% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 137 | -97.1% | 0.00% | – |
Q2 2022 | $4,000 | -69.2% | 4,765 | -52.0% | 0.00% | – |
Q1 2022 | $13,000 | -55.2% | 9,924 | -44.2% | 0.00% | – |
Q4 2021 | $29,000 | -93.8% | 17,794 | -89.9% | 0.00% | – |
Q3 2021 | $464,000 | -29.7% | 175,933 | -8.8% | 0.00% | – |
Q2 2021 | $660,000 | -34.6% | 192,887 | -3.6% | 0.00% | – |
Q1 2021 | $1,009,000 | +275.1% | 200,118 | +250.1% | 0.00% | – |
Q4 2020 | $269,000 | +156.2% | 57,164 | -45.6% | 0.00% | – |
Q2 2020 | $105,000 | -97.1% | 105,012 | -52.3% | 0.00% | -100.0% |
Q1 2020 | $3,662,000 | +993.1% | 220,373 | 0.0% | 0.00% | – |
Q4 2019 | $335,000 | -90.9% | 220,373 | -0.4% | 0.00% | -100.0% |
Q3 2019 | $3,678,000 | 0.0% | 221,311 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $3,678,000 | -35.8% | 221,311 | -35.8% | 0.00% | 0.0% |
Q1 2019 | $5,725,000 | +739.4% | 344,478 | 0.0% | 0.00% | – |
Q4 2018 | $682,000 | -36.3% | 344,478 | 0.0% | 0.00% | – |
Q3 2018 | $1,071,000 | -80.6% | 344,478 | +3.7% | 0.00% | -100.0% |
Q2 2018 | $5,520,000 | +1.7% | 332,140 | +1.7% | 0.00% | 0.0% |
Q1 2018 | $5,427,000 | +441.1% | 326,566 | 0.0% | 0.00% | – |
Q4 2017 | $1,003,000 | -76.0% | 326,566 | +29.8% | 0.00% | -100.0% |
Q3 2017 | $4,180,000 | +2.5% | 251,527 | +2.5% | 0.00% | 0.0% |
Q2 2017 | $4,079,000 | 0.0% | 245,425 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $4,079,000 | +399.9% | 245,425 | +53.4% | 0.00% | – |
Q4 2016 | $816,000 | -69.3% | 160,000 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $2,659,000 | 0.0% | 160,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $2,659,000 | 0.0% | 160,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $2,659,000 | +301.1% | 160,000 | +113.3% | 0.00% | – |
Q2 2015 | $663,000 | +145.6% | 75,000 | +145.0% | 0.00% | – |
Q1 2015 | $270,000 | -15.9% | 30,618 | -12.0% | 0.00% | – |
Q4 2014 | $321,000 | -80.3% | 34,811 | -71.9% | 0.00% | – |
Q3 2014 | $1,632,000 | -51.0% | 124,022 | -39.0% | 0.00% | -100.0% |
Q2 2014 | $3,333,000 | -27.0% | 203,456 | -15.1% | 0.00% | 0.0% |
Q1 2014 | $4,565,000 | +206.2% | 239,608 | +215.7% | 0.00% | – |
Q4 2013 | $1,491,000 | – | 75,903 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eidelman Virant Capital | 117,000 | $101,000 | 0.07% |
SILVERARC CAPITAL MANAGEMENT, LLC | 202,322 | $156,000 | 0.05% |
Senvest Management, LLC | 230,606 | $178,000 | 0.01% |
Susquehanna International Group Ltd. | 28,718 | $21,000 | 0.01% |
Vident Investment Advisory, LLC | 87,714 | $68,000 | 0.00% |
MGO ONE SEVEN LLC | 15,340 | $12,000 | 0.00% |
Csenge Advisory Group | 31,962 | $24,000 | 0.00% |
SNS Financial Group, LLC | 10,000 | $8,000 | 0.00% |
Sigma Planning Corp | 31,810 | $24,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 10,249 | $8,000 | 0.00% |